Zai Lab Limited
ZLABNASDAQHealthcare● Active
$16.44
$-0.18(-1.10%)
Market Cap$1.8B
P/E Ratio—
52W High$44.34
52W Low$15.96
Zai Lab Limited (ZLAB) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ZLAB · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.46B | $0.40B | $0.27B | $0.22B | $0.14B |
| Cost of Revenue | $0.19B | $0.15B | $0.10B | $0.07B | $0.05B |
| Gross Profit | $0.27B | $0.25B | $0.17B | $0.14B | $0.09B |
| Gross Margin %(computed) | 58.47% | 62.94% | 64.08% | 65.58% | 63.80% |
| Operating Expenses | |||||
| R&D Expenses | $0.22B | $0.23B | $0.27B | $0.29B | $0.57B |
| G&A Expenses | $0.28B | $0.30B | $0.28B | $0.20B | $0.22B |
| Total Operating Expenses | $0.49B | $0.53B | $0.54B | $0.55B | $0.79B |
| Operating Income | ($0.22B) | ($0.28B) | ($0.37B) | ($0.40B) | ($0.70B) |
| Operating Margin %(computed) | -48.59% | -70.71% | -137.44% | -188.04% | -485.10% |
| Interest Income | $0.03B | $0.04B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.18B) | ($0.26B) | ($0.33B) | ($0.44B) | ($0.70B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.18B) | ($0.26B) | ($0.33B) | ($0.44B) | ($0.70B) |
| Net Margin %(computed) | -38.15% | -64.44% | -125.46% | -206.14% | -488.16% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.60 | $-2.60 | $-34.60 | $-46.30 | $-75.80 |
| Wtd Avg Shares | 0.11B | 0.10B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.16B) | ($0.23B) | ($0.37B) | ($0.43B) | ($0.69B) |
| EBITDA Margin %(computed) | -34.39% | -58.79% | -136.89% | -202.21% | -477.76% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Zai Lab Limited data
About Zai Lab Limited (ZLAB) Income Statement
Zai Lab Limited (ZLAB) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ZLAB reported revenue of $0.46B, gross profit of $0.27B (gross margin 58.47%), and net income of ($0.18B) — a net profit margin of -38.15%.
Frequently asked questions
ZLAB · 4 questionsZai Lab Limited (ZLAB) reported revenue of $0.46B for 2025, up 15.3% year-over-year.
ZLAB revenueZLAB salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08